Regulatory milestones

ALK-Abello A/S (CSE:ALK-B) gained DKK5 to DKK723 last week after FDA's Allergenic Products Advisory Committee voted 6-2, with one abstention, that available data support the efficacy of Ragwitek ragweed Allergy Immunotherapy Tablet (AIT) to treat ragweed pollen-induced allergic rhinitis.